Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
- PMID: 32914978
- PMCID: PMC7949482
- DOI: 10.1021/acs.jmedchem.0c00926
Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
Abstract
GPR18 is a G-protein-coupled receptor that belongs to the orphan class A family. Even though it shares low sequence homology with the cannabinoid receptors CB1R and CB2R, a growing body of research suggests its relationship with the endocannabinoid system, not only because it is able to recognize cannabinoid ligands but also because of its expression and ability to heteromerize with CBRs. In this review, we aim to analyze the biological relevance, reported modulators, and structural features of GPR18. In order to guide future drug design in this field, highlights from molecular modeling of GPR18 will be provided.
Figures
References
-
- Gantz I; Muraoka A; Yang YK; Samuelson LC; Zimmerman EM; Cook H; Yamada T Cloning and Chromosomal Localization of a Gene (GPR18) Encoding a Novel Seven Transmembrane Receptor Highly Expressed in Spleen and Testis. Genomics 1997, 42 (3), 462–466. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
